Pharmaceutical Exporter from India to Cambodia
WHO-GDP–aligned export of quality-assured generic and specialty medicines to Cambodian importers, wholesalers, hospitals, NGOs and pharmacies — with full DDF registration documentation support.
Indian Generic Medicines (IGM) is an India-based pharmaceutical exporter serving the Cambodian market. We facilitate the supply of WHO-GMP, EU-GMP, PIC/S and USFDA-sourced generic and specialty medicines to licensed Cambodian buyers, and provide the dossiers and certificates needed for registration with Cambodia's Department of Drugs and Food (DDF).
B2B trade information only — not medical advice. All products are supplied to licensed entities and are subject to Cambodian registration and local licensing.
Why Cambodian buyers source medicines from India
India is one of the world's largest suppliers of affordable generic medicines and a primary source for the Cambodian market. Because Cambodia relies on imports for most of its medicine supply, a dependable, documentation-ready Indian partner directly supports continuity of care.
India–Cambodia pharmaceutical trade at a glance
Two different metrics are often confused. India sends the largest number of shipments; by dollar value it is one of several major suppliers. Both are shown separately below, with sources.
| Indicator | Figure | Basis / source |
|---|---|---|
| India's share of Cambodia's pharma shipments | ~86% of shipments (Oct 2023–Sep 2024) | Volza shipment-count data — a volume metric, not value |
| India→Cambodia pharma export value | ~US$51.6 million (2023) | UN COMTRADE / Trading Economics |
| Cambodia total pharma market (revenue) | ~US$444 million (2024), CAGR ~6.45% to 2028 | Statista segment (estimates vary by definition) |
| Import reliance | Over 90% of pharma products imported | U.S. Department of Commerce |
| Population | 17 million+ | National / UN data |
| Regulator | Ministry of Health → Department of Drugs and Food (DDF) | Cambodia MoH / DDF |
How to import medicines from India to Cambodia
A clear, compliant pathway — and exactly where IGM supports you.
IGM supports dossier preparation, QA release and GDP-compliant logistics directly, and coordinates with your local agent on registration. We do not bypass or accelerate regulatory review.
Why choose Indian Generic Medicines (IGM)
| Capability | IGM | Typical trading broker |
|---|---|---|
| Source-facility accreditation transparency | ✓ Documented | Often unclear |
| DDF dossier / CoPP support | ✓ Yes | Partial |
| Cold-chain / WHO-GDP logistics | ✓ Yes | Varies |
| Specialty (oncology, biologics) range | ✓ Yes | Limited |
| Named regulatory point of contact | ✓ Yes | Rare |
Certifications & quality assurance
IGM sources from facilities accredited to internationally recognised standards and operates a WHO-GDP–aligned distribution chain.
Certificates and facility accreditations are available to qualified buyers on request (under NDA where applicable).
Medicines & therapy areas we supply
Availability of all products is subject to Cambodian regulations and product registration status. This page is B2B trade information, not medical advice.
Cambodian buyers we support
Cambodia's pharmaceutical market overview
Cambodia's pharmaceutical market has grown steadily, driven by rising healthcare demand, a young and expanding population of 17 million+, and government investment in medical infrastructure. According to Statista, the market is estimated at roughly US$444 million in revenue for 2024, with a compound annual growth rate of about 6.45% from 2024 to 2028. Estimates vary by source and definition.
Cambodia depends heavily on imports: the U.S. Department of Commerce reports the country imports over 90% of its pharmaceutical products, particularly from India, Thailand, China and France, with domestic production covering only a small share of demand. Regulation is overseen by the Ministry of Health through the Department of Drugs and Food (DDF), which manages product registration and licensing; foreign companies must appoint a local agent or distributor to register products, and ongoing ASEAN regulatory harmonisation is gradually simplifying cross-border trade.
Challenges & how IGM addresses them
Complex regulatory landscape — DDF registration can be time-consuming, with periodic policy updates.
DDF-ready CTD dossiers, CoPP and GMP certificates, coordinated with your local agent for smoother submission.
Infrastructure & logistics constraints — limited transport/warehousing and cold-chain risk.
WHO-GDP–aligned logistics, validated cold-chain handling and end-to-end shipment coordination.
Cost pressures — import duties, taxes and compliance costs raise operating expenses.
Competitive, generic-led pricing and transparent documentation that reduces rework and delays.
Regional competition — suppliers from China and Thailand and local manufacturers.
Accredited sourcing, specialty range and a named regulatory point of contact to build buyer trust.
Trust & transparency
Scope: IGM supplies pharmaceutical products only to licensed entities, subject to local registration. This page provides B2B trade information and is not medical advice or a solicitation to patients.
Regulatory Affairs & International Trade Lead, IGM — 10+ years in pharmaceutical export, with DDF/ASEAN registration experience.
QA-RA professional. Reviewed for accuracy of regulatory and product-category statements. Review date: June 2026.
Frequently asked questions
Indian Generic Medicines (IGM) exports quality-assured generic, branded and specialty medicines from India to licensed Cambodian buyers — importers, wholesalers, hospitals, NGOs and pharmacies — with DDF registration documentation support.
India supplies the largest number of pharmaceutical shipments to Cambodia (around 86% of shipment volume in 2023–2024, per Volza). By import value, India is one of several leading suppliers alongside China, Thailand, France and Vietnam.
India-to-Cambodia pharmaceutical exports were about US$51.6 million in 2023 (UN COMTRADE). India also leads by number of shipments, at roughly 86% of Cambodia's pharma shipments in 2023–2024.
Products must be registered and licensed with Cambodia's Department of Drugs and Food (DDF) under the Ministry of Health, and a registered local Cambodian agent or distributor must hold the registration.
Domestic manufacturing is limited, so Cambodia imports a large share of its medicines — the U.S. Department of Commerce cites over 90%. Major sources include India, Thailand, China and France.
Yes. IGM supplies affordable, quality-assured generics across major therapeutic categories — including oncology, anti-infectives, cardiovascular, anti-diabetic and neurology medicines — subject to Cambodian registration.
IGM supports CTD dossiers, Certificate of Pharmaceutical Product (CoPP), GMP certificates and product specifications, coordinated with your local Cambodian agent. IGM does not bypass or accelerate regulatory review.
Need a reliable pharmaceutical exporter for Cambodia?
For your importing business, hospital, pharmacy, NGO or distribution network — IGM supports product availability, transparent pricing, DDF registration documentation and reliable, GDP-compliant logistics.
